Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

11 Dec 2025 07:00

RNS Number : 0875L
S & U PLC
11 December 2025
Β 

11 December 2025

S&U plc

("S&U" or "the Group")

TRADING STATEMENT

S&U PLC (LSE: SUS), the specialist motor and property finance lender today issues its trading update for the period 5th August 2025 to 10th December 2025.

Β 

Business Highlights

Β 

The turnaround in S&U's fortunes, predicted in our last trading statement of early August, and confirmed at our interim results in October, continues apace. Group profit at the end of the third quarter continues to beat budget. Trading, particularly at Advantage, our motor finance business, is healthy both in terms of new business volumes and quality. As a result, group net receivables, the life blood of future profitability, now stand at c.Β£491 m (2024: Β£447 m) and are accelerating month by month.

Β 

This surge clearly confirms the abilities of our businesses, once freed from the shackles of regulatory intervention. The lifting of the FCA's s166 process at Advantage in April, and the calming effect that the Supreme Court's sensible decisions on commission disclosure in early August have had on the wider industry, presage a firmer motor finance market. Indeed, the latest Finance and Leasing Association statistics show the used car finance market up by 6% in September, having declined slightly by 2% in the preceding months.

Β 

By comparison, the performance of both Advantage and Aspen has been remarkably resilient given the chaotic and monumentally mishandled recent budget, and its dampening effect on consumer confidence in general and more specifically on the housing market. Ironically, a happy consequence now appears to be a dawning realisation within the Treasury and the FCA that without growth and greater access to credit, consumer satisfaction and protection are pretty hypothetical.

Β 

Advantage Finance

The last four months have seen an upsurge in trading at Advantage, led by CEO Karl Werner. Recent monthly agreement volumes have averaged 2,500, or over Β£25m in value compared to 7,121 deals in the first half. Advantage's third quarter, to the 31st of October, saw a record 869,000 finance applications, and now receivables are a net c.Β£318m, an increase of 14% on the previous quarter.

Β 

This has given Advantage the opportunity to both improve its interest margins, especially amongst higher tier customers and, with a renewed scorecard and updated affordability measures, also improve the quality of its loan book. As a result, latest collection rates for November are at a record 93.4% of due. Recency statistics on collections are at their best level for two years. The very compliant way in which Advantage manages and guides its customers who fall into arrears is shown by the most recent figures on the number and size of successful repayment arrangements. In this way Advantage can assist its customers to protect and improve their credit ratings - an attribute too little recognised in the non-prime market.

Β 

We would encourage the Financial Conduct Authority to remember this when addressing industry concerns about its Commission Redress scheme which is currently under consultation. Advantage is only tangentially affected by this commission debate, having never employed discretionary commission

Β 

("DCAs"); or tied arrangements; Advantage estimates that only 2.4% of its customers even potentially qualify for redress consideration under the proposed rules. Nevertheless, in conjunction with the Finance and Leasing Association, Advantage has produced a comprehensive and constructive response to the FCA, which proposes reductions in scope of redress and a much more focused and efficient process.

Β 

Whatever the outcome, the company anticipates that the effect of commission redress upon Advantage's current robust trading performance will be minimal. Its strong rebound should continue unabated.

Β 

Aspen Bridging

Β 

Despite the drag on transactions in the residential property market caused by the government prevarication mentioned earlier, Aspen continues to sensibly grow its loan book. At half year net receivables stood at Β£148m. At the end of the period under review these are now c.Β£173m.

Β 

Repayments in the period were at Β£47m and year to date they are ahead of budget at Β£160m. Advances in the period were Β£75m, driven by a greater number of smaller deals for bridging products augmented by our very popular Buy to Let loans the average size of which is over Β£1.3m. Margins are stable and on budget. Application numbers were inevitably affected by drawn out budget speculation and then imposition of higher taxes on rental incomes, council tax extensions and a new mansion tax; however, these have rebounded in the last three weeks.

Β 

The quality of Aspen's loan book also remains good with just 16 out of 240 loans beyond term. Aspen is making steady progress on resolving the very small number of longer-term cases.

Β 

Although it is to be hoped that lower interest rates will produce a significant but unlikely revival in the UK's hidebound residential market, Aspen will nevertheless produce a solid second half and another good profit for the year as a whole.

Β 

Funding

Β 

The very welcome acceleration in activity throughout the Group of the past few months has seen Group net borrowings rise to Β£241m from Β£180m at the half year. Whilst the existing funding capacity of Β£280m will meet our requirements for the immediate future, an exciting project is at present under way to confirm substantially larger, but flexible, medium-term facilities on a competitive basis. These will facilitate the expansion we foresee for both businesses over the next three years.

Β 

Commenting on S&U's trading outlook, Anthony Coombs, S&U Chairman, said:

"Recent months have undoubtedly confirmed that S&U has regained its "Va Va Voom"; to quote my predecessor's habitual phrase. It is also true that investors are increasingly aware of the value inherent in family-controlled SME businesses with rewarding dividend policies. With both Advantage and Aspen on the right track, we have every confidence in the good rewards for shareholders we anticipate in the years to come".

Β 

Β 

Β 

Β 

Β 

For further information, please contact:

Enquiries

Anthony Coombs

S&U plc

c/o SEC Newgate

Financial Public Relations

Bob Huxford, Harry Handyside, Aqsa Ali

SEC Newgate

020 7653 9848

Broker

Andrew Buchanan, Rob Parker

Peel Hunt LLP

020 7418 8900

Broker

James Felix, John Welch, Daniel Gee-Summons

Berenberg

020 3207 7800

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBRBDDCXBDGUG
Date   Source Headline
9th Apr 20217:00 amEQSEdison Investment Research Limited: S&U (SUS): Ready to meet unlocked demand
30th Mar 20217:00 amRNSPreliminary Results
18th Mar 20217:00 amRNSInvestor Presentation
11th Feb 202110:00 amRNSCORRECTION: TRADING STATEMENT & NOTICE OF RESULTS
11th Feb 20217:00 amRNSTrading Statement and Notice of Results
27th Jan 20213:40 pmRNSDirector/PDMR Shareholding
9th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSTrading Statement
23rd Nov 20209:55 amRNSBlock Listing Six Monthly Return
30th Sep 20207:01 amRNSDirectorate Change
30th Sep 20207:00 amRNSInterim Results
24th Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSNotice of Results
28th Aug 20203:36 pmRNSHolding(s) in Company
28th Aug 20203:35 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
31st Jul 20203:06 pmRNSTotal Voting Rights
30th Jun 20205:47 pmRNSTotal Voting Rights
9th Jun 20201:10 pmRNSResult of AGM
9th Jun 20207:00 amRNSAGM Statement and Trading Update
1st Jun 202010:25 amRNSTotal Voting Rights
22nd May 20209:35 amRNSBlock Listing Six Monthly Return
13th May 202012:50 pmRNSDirector/PDMR Shareholding
6th May 20202:00 pmRNSAnnual Report and Accounts
1st May 20207:00 amRNSTotal Voting Rights
15th Apr 20204:55 pmRNSBlock Listing Application
9th Apr 20204:42 pmRNSSecond Price Monitoring Extn
9th Apr 20204:37 pmRNSPrice Monitoring Extension
8th Apr 20202:04 pmRNSPreliminary Results: Replacement
8th Apr 20207:00 amRNSPreliminary Results
6th Apr 20207:00 amRNSNotice of Results
23rd Mar 20207:00 amRNSDelay to Publication of Full Year Results
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20204:41 pmRNSSecond Price Monitoring Extn
20th Feb 20204:36 pmRNSPrice Monitoring Extension
11th Feb 20207:00 amRNSTrading Statement and Notice of Results
7th Jan 20203:19 pmRNSExercise and Sale of Options, Total Voting Rights
18th Dec 20195:40 pmRNSExercise and Sale of Options, Total Voting Rights
10th Dec 20197:00 amRNSTrading Statement
2nd Dec 20192:42 pmRNSBlock listing Six Monthly Return
23rd Oct 20193:38 pmRNSExercise and Sale of Options & Total Voting Rights
22nd Oct 20192:00 pmRNSExercise and Sale of Options & Total Voting Rights
17th Oct 20194:55 pmRNSExercise of Options and Total Voting Rights
24th Sep 20197:01 amRNSAppointment by Advantage Finance of New CEO
24th Sep 20197:00 amRNSInterim Results
15th Aug 201912:08 pmRNSSecond Price Monitoring Extn
15th Aug 201912:02 pmRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSTrading Update and Notice of Results
1st Aug 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.